podophyllin and Neoplasms

podophyllin has been researched along with Neoplasms* in 67 studies

Reviews

2 review(s) available for podophyllin and Neoplasms

Article	Year
[Side-effects of cytostatic therapy with special reference to potential carcinogenic effects]. Der Internist, 1971, Volume: 12 Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Busulfan; Fluorouracil; Hemangiosarcoma; Mercaptopurine; Mitomycins; Neoplasms; Neoplasms, Experimental; Podophyllin; Rats; Sarcoma, Experimental; Thiotepa; Vinblastine	1971
Multiple combination therapy in cancer chemotherapy in Japan. Gan, 1969, Volume: 60, Issue:3 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Chloroquine; Cyclophosphamide; Cytarabine; Drug Synergism; Fluorouracil; Humans; Japan; Leukemia; Lymphoma; Mercaptopurine; Mitomycins; Neoplasms; Podophyllin; Prednisolone; Thiotepa; Vincristine; Vitamin K 1	1969

Article

Year

[Side-effects of cytostatic therapy with special reference to potential carcinogenic effects].

Der Internist, 1971, Volume: 12

Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Busulfan; Fluorouracil; Hemangiosarcoma; Mercaptopurine; Mitomycins; Neoplasms; Neoplasms, Experimental; Podophyllin; Rats; Sarcoma, Experimental; Thiotepa; Vinblastine

1971

Multiple combination therapy in cancer chemotherapy in Japan.

Gan, 1969, Volume: 60, Issue:3

Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Chloroquine; Cyclophosphamide; Cytarabine; Drug Synergism; Fluorouracil; Humans; Japan; Leukemia; Lymphoma; Mercaptopurine; Mitomycins; Neoplasms; Podophyllin; Prednisolone; Thiotepa; Vincristine; Vitamin K 1

1969

Trials

2 trial(s) available for podophyllin and Neoplasms

Article	Year
A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin. British journal of cancer, 2001, Apr-20, Volume: 84, Issue:8 Pre-clinical studies indicate that cisplatin encapsulated in STEALTH((R))liposomes (SPI-77) retains anti-tumour activity, but has a much reduced toxicity, compared to native cisplatin. A phase I study was conducted to determine the toxicity and pharmacokinetics of SPI-77 administered to children with advanced cancer not amenable to other treatment. Paediatric patients were treated at doses ranging from 40 to 320 mg m(-2)by intravenous infusion every 4 weeks. Blood samples taken during, and up to 3 weeks after, administration and plasma and ultrafiltrate were prepared immediately. Urine was collected, when possible, for 3 days after administration. SPI-77 administration was well tolerated with the major toxicity being an infusion reaction which responded to modification of the initial infusion rate of SPI-77. Limited haematological toxicity and no nephrotoxicity were observed. No responses to treatment were seen during the course of this phase I study. Measurement of total plasma platinum showed that cisplatin was retained in the circulation with a half life of up to 134 h, with maximum plasma concentrations approximately 100-fold higher than those reported following comparable doses of cisplatin. Comparison of plasma and whole blood indicated that cisplatin was retained in the liposomes and there was no free platinum measurable in the ultrafiltrate. Urine recovery was less than 4% of the dose administered over 72 h. Results from this phase I study indicate that high doses of liposomal cisplatin can safely be given to patients, but further studies are required to address the issue of reformulation of liposomally bound cisplatin. Topics: Adolescent; Antineoplastic Agents; Area Under Curve; Child; Child, Preschool; Cholesterol; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Infant; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Liposomes; Male; Neoplasms; Podophyllin; Podophyllotoxin; Time Factors; Triglycerides	2001
[5-year results of combined treatment with the cobalt bomb and the cytostatic preparation SP-G and SP-I (Sandoz)]. Deutsche medizinische Wochenschrift (1946), 1965, Nov-26, Volume: 90, Issue:48 Topics: Antineoplastic Agents; Cobalt Isotopes; Humans; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum	1965

Article

Year

A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin.

British journal of cancer, 2001, Apr-20, Volume: 84, Issue:8

Pre-clinical studies indicate that cisplatin encapsulated in STEALTH((R))liposomes (SPI-77) retains anti-tumour activity, but has a much reduced toxicity, compared to native cisplatin. A phase I study was conducted to determine the toxicity and pharmacokinetics of SPI-77 administered to children with advanced cancer not amenable to other treatment. Paediatric patients were treated at doses ranging from 40 to 320 mg m(-2)by intravenous infusion every 4 weeks. Blood samples taken during, and up to 3 weeks after, administration and plasma and ultrafiltrate were prepared immediately. Urine was collected, when possible, for 3 days after administration. SPI-77 administration was well tolerated with the major toxicity being an infusion reaction which responded to modification of the initial infusion rate of SPI-77. Limited haematological toxicity and no nephrotoxicity were observed. No responses to treatment were seen during the course of this phase I study. Measurement of total plasma platinum showed that cisplatin was retained in the circulation with a half life of up to 134 h, with maximum plasma concentrations approximately 100-fold higher than those reported following comparable doses of cisplatin. Comparison of plasma and whole blood indicated that cisplatin was retained in the liposomes and there was no free platinum measurable in the ultrafiltrate. Urine recovery was less than 4% of the dose administered over 72 h. Results from this phase I study indicate that high doses of liposomal cisplatin can safely be given to patients, but further studies are required to address the issue of reformulation of liposomally bound cisplatin.

Topics: Adolescent; Antineoplastic Agents; Area Under Curve; Child; Child, Preschool; Cholesterol; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Infant; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Liposomes; Male; Neoplasms; Podophyllin; Podophyllotoxin; Time Factors; Triglycerides

2001

[5-year results of combined treatment with the cobalt bomb and the cytostatic preparation SP-G and SP-I (Sandoz)].

Deutsche medizinische Wochenschrift (1946), 1965, Nov-26, Volume: 90, Issue:48

Topics: Antineoplastic Agents; Cobalt Isotopes; Humans; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum

1965

Other Studies

63 other study(ies) available for podophyllin and Neoplasms

Article	Year
Cancer morbidity in rheumatoid arthritis patients treated with Proresid or parenteral gold. Scandinavian journal of rheumatology, 1995, Volume: 24, Issue:2 The cancer risk was studied by comparison of 305 rheumatoid arthritis (RA) patients exposed to Proresid during a mean time of 22 months and 305 RA patients exposed to sodium aurothiomalate during a mean time of 19 months with the regional cancer register. The mean observation time was 6.9 years (2,117 person-years) for the Proresid-treated and 7.5 years (2,293 person-years) for the gold-treated patients. No increased risk of total malignancies was observed for either group. However, looking at separate tumours, an increased risk of lymphoma and leukemia was found although only significant in the gold-treated group. It was not correlated to dosage or duration of either therapy. The increased risk is consistent with earlier reports of an increased risk of hematopoietic malignancies in RA patients. Marginal over and underreporting, particularly of hematopoietic malignancies, were observed, mainly due to clinicians' failure to report and to recall false reports. Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Cohort Studies; Female; Gold Sodium Thiomalate; Humans; Infusions, Parenteral; Male; Morbidity; Neoplasms; Podophyllin; Podophyllotoxin; Risk Factors; Sweden	1995
Proresid therapy in rheumatoid arthritis. A comparison with injectable gold using life-table analysis. Scandinavian journal of rheumatology, 1993, Volume: 22, Issue:2 Proresid, mainly consisting of podophyllotoxin derivatives and two glycosides thereof, has been used as a disease-modifying antirheumatic drug in Sweden since the late 1960s. A life-table analysis of Proresid treatment averaging 41 months (range 4-144) in 79 rheumatoid arthritis patients showed a termination rate of 40, 56, 75 and 85% after 1/2, 1, 2 and 4 years, respectively. Dominant reasons for discontinuing therapy were inefficacy (37%) and gastrointestinal symptoms (35%). The risk of discontinuation of therapy due to inefficacy was constant over time, while the risk due to other causes, including side effects, gradually decreased. A comparison with injectable gold therapy showed, after adjusting for confounding factors, that the total termination incidence was higher (p < 0.05) in the Proresid-treated patients. A comparison with the regional cancer register of 334 patients exposed to Proresid for a mean time of 2.2 years showed no increased cancer risk after a mean observation time of 6.1 years. Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cohort Studies; Female; Gold; Humans; Incidence; Injections; Life Tables; Male; Middle Aged; Neoplasms; Patient Compliance; Patient Dropouts; Podophyllin; Podophyllotoxin; Prognosis; Risk Factors; Treatment Outcome	1993
Side effects of Proresid in the treatment of chronic arthritis. Scandinavian journal of rheumatology, 1988, Volume: 17, Issue:1 Topics: Aged; Amyloidosis; Arthritis; Diarrhea; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Neoplasms; Podophyllin; Podophyllotoxin	1988
Structure-activity relationships of podophyllin congeners that inhibit topoisomerase II. NCI monographs : a publication of the National Cancer Institute, 1987, Issue:4 Various analogs of etoposide have been studied and compared in different tests in order to identify which tests best correlate with antitumor activity. These tests included DNA breakage assays using standard alkaline elution procedures as a means of studying topoisomerase II inhibition in intact cells, cytotoxicity studies in naturally sensitive and resistant human carcinoma cell lines, in vitro assays of the effect of the different congeners on topoisomerase II activity, and a preliminary evaluation of the ability of etoposide and teniposide to induce resistance. As in previous studies, a direct correlation was seen between double strand DNA breakage and cytotoxicity but not between single strand DNA breakage and cytotoxicity. Analogs with blocked 4'-hydroxyl groups were poor antitumor agents but were still capable of inhibiting topoisomerase II as evidenced by the production of DNA breaks. However, this DNA breakage was qualitatively different from that produced by VP16. None of the analogs were able to overcome either naive or acquired drug resistance. The dihydroxy analog of VP16, a possible bioactivated analog, was much less potent and possibly less stable than VP16. A model is proposed for the inhibition of topoisomerase II by demethylepipodophyllotoxins that may explain the relationship between double strand DNA breakage and cytotoxicity. Topics: Cell Line; DNA, Neoplasm; Drug Resistance; Humans; Neoplasms; Podophyllin; Structure-Activity Relationship; Topoisomerase II Inhibitors	1987
The diagnostic value of circulating trophoblast-specific beta 1-glycoprotein (TSG) in cancer patients. British journal of cancer, 1980, Volume: 41, Issue:5 Topics: Female; Humans; Hydrazines; Male; Neoplasms; Podophyllin; Podophyllotoxin; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms	1980
[The effects of cytostatic agents on short-term cultures (3H-uridine incorporation) and tissue cultures (cell counts) from human tumors (author's transl)]. Archiv fur Gynakologie, 1974, May-14, Volume: 216, Issue:3 Topics: Antineoplastic Agents; Bleomycin; Cell Count; Cell Transformation, Neoplastic; Cells, Cultured; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Female; Fluorouracil; Humans; In Vitro Techniques; Methods; Methotrexate; Neoplasms; Ovarian Neoplasms; Podophyllin; Suspensions; Time Factors; Triaziquone; Tritium; Uridine	1974
Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors. Cancer chemotherapy reports, 1972, Volume: 56, Issue:1 Topics: Adult; Aged; Animals; Antineoplastic Agents; Female; Glycosides; Haplorhini; Hodgkin Disease; Humans; Immunosuppression Therapy; Lactones; Lymphoma; Male; Mice; Middle Aged; Neoplasms; Neoplasms, Experimental; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Rats; Thiophenes	1972
[Studies on the understanding of problems of radiologic cytostatic combination treatment. 6. Further syncytostatic studies with 5-fluorouracil, natulan and proresid]. Strahlentherapie, 1969, Volume: 138, Issue:2 Topics: Amides; Animals; Antineoplastic Agents; Cyclophosphamide; Ear, External; Female; Fluorouracil; Granulation Tissue; Hydrazines; Mice; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Radiation Effects; Radiation Injuries, Experimental; Radiotherapy Dosage; Statistics as Topic; Tail; Wound Healing	1969
[Considerations on the use of Proresid (SPI-SPG Sandoz) as an adjuvant in the treatment of tumors (preliminart communication)]. Hospital (Rio de Janeiro, Brazil), 1968, Volume: 74, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Female; Humans; Male; Middle Aged; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum	1968
[Therapeutic effects of podophyllin derivatives on malignant neoplasms]. Hospital (Rio de Janeiro, Brazil), 1968, Volume: 73, Issue:1 Topics: Aged; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum	1968
[Clinical use of podophyllin derivatives SP-I and SP-G in the treatment of cancer]. Gan no rinsho. Japan journal of cancer clinics, 1968, Volume: 14, Issue:12 Topics: Adult; Female; Humans; Male; Middle Aged; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum	1968
Human anticancer effect of podophyllum derivatives (SPG and SPI): a preliminary report. British journal of cancer, 1967, Volume: 21, Issue:1 Topics: Adult; Deglutition Disorders; Esophageal Neoplasms; Gingiva; Humans; Injections, Intra-Arterial; Male; Mandibular Neoplasms; Mouth; Mouth Neoplasms; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum	1967
SPI and SPG in the treatment of advanced malignant lesions. International surgery, 1967, Volume: 48, Issue:4 Topics: Alkylating Agents; Antimetabolites; Antineoplastic Agents; Hormones; Humans; Leukopenia; Neoplasms; Paralysis; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum	1967
[New possibilities in testing resistance of human carcinoma tissue to cytostatic agents in vivo]. Deutsche medizinische Wochenschrift (1946), 1967, May-19, Volume: 92, Issue:20 Topics: Animals; Cyclophosphamide; Humans; Methotrexate; Neoplasm Transplantation; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Rats; Thiotepa; Triaziquone	1967
[Clinical experiences with SP-I]. Gan no rinsho. Japan journal of cancer clinics, 1967, Volume: 13, Issue:9 Topics: Humans; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum	1967
[Cytostatic chemotherapy in the treatment of malignant tumors]. Arztliche Forschung, 1966, Aug-10, Volume: 20, Issue:8 Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Hematopoiesis; Humans; Kidney Neoplasms; Leukopenia; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasms; Podophyllin; Rectal Neoplasms; Triaziquone	1966
[Submicroscopic changes in human cancer cells under the effect of SP-I and SP-G "Sandoz"]. Oncology, 1966, Volume: 20, Issue:4 Topics: Aged; Antineoplastic Agents; Female; Humans; Male; Microscopy, Electron; Middle Aged; Neoplasms; Otorhinolaryngologic Diseases; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum	1966
[Treatment of malignant tumors with SP-I/SP-G Sandoz (Proresid)]. Therapeutische Umschau. Revue therapeutique, 1966, Volume: 23, Issue:12 Topics: Adult; Antineoplastic Agents; Female; Humans; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum	1966
GIANT CONDYLOMA AND VERRUCOUS CARCINOMA OF THE GENITAL AREA. Archives of pathology, 1965, Volume: 79 Topics: Buschke-Lowenstein Tumor; Carcinoma, Squamous Cell; Carcinoma, Verrucous; Genitalia, Male; Humans; Lymphatic Metastasis; Male; Neoplasms; Papilloma; Pathology; Penile Neoplasms; Podophyllin; Podophyllum; Scrotum; Skin Neoplasms; Surgical Procedures, Operative	1965
[THE VALUE OF THE ADDITION OF A PODOPHYLLUM TOXIN COMPOUND TO THE SURGICAL AND RADIOLOGICAL TREATMENT OF MAMMARY CARCINOMAS]. Radiologia clinica, 1965, Volume: 34 Topics: Antineoplastic Agents; Breast Neoplasms; Humans; Neoplasms; Podophyllin; Podophyllum; Toxicology	1965
[LATEST RESEARCH ON ALTERATIONS OF THE MUCOSA AND SKIN OF THE LIP OF THE RAT CAUSED BY PODOPHYLLIN]. Archivio italiano di anatomia e istologia patologica, 1965, Volume: 39 Topics: Carcinogens; Lip; Mucous Membrane; Necrosis; Neoplasms; Neoplasms, Experimental; Podophyllin; Podophyllum; Rats; Research; Skin Ulcer; Toxicology	1965
[Cytostatic therapy of metastatic and advanced malignant tumors of the ENT region with podophyllin derivatives (SPI-SPG)]. Radovi Medicinskog faculteta u Zagrebu, 1965, Volume: 13, Issue:1 Topics: Humans; Neoplasms; Otorhinolaryngologic Diseases; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum	1965
FATAL POISONING WITH PODOPHYLLUM RESIN. JAMA, 1964, Nov-09, Volume: 190 Topics: Antineoplastic Agents; Female; Humans; Neoplasms; Ovarian Neoplasms; Plant Poisoning; Podophyllin; Podophyllum; Resins, Synthetic; Toxicology	1964
[ATTEMPTED TREATMENT OF CANCER IN AN ADVANCED STAGE BY PODOPHYLLIN DERIVATIVES]. Bruxelles medical, 1964, Oct-11, Volume: 44 Topics: Antineoplastic Agents; Drug Therapy; Geriatrics; Neoplasms; Podophyllin; Podophyllum; Toxicology	1964
[ON GENERAL AND LOCAL ANTIMITOTIC THERAPY OF GENITAL CARCINOMA WITH THE PODOPHYLLINIC DERIVATIVES SP-I AND SP-G]. Minerva ginecologica, 1964, Nov-15, Volume: 16 Topics: Antimitotic Agents; Antineoplastic Agents; Carcinoma; Female; Genital Neoplasms, Female; Geriatrics; Humans; Neoplasms; Podophyllin; Podophyllum; Toxicology	1964
[THE DISTRIBUTION OF THE ANTIMITOTIC AGENT, ETHYLHYDRAZIDE OF PODOPHYLLIC ACID (SP-I 77) IN THE BODY AND IN HUMAN MALIGNANT TUMORS]. Klinische Wochenschrift, 1964, Oct-15, Volume: 42 Topics: Animals; Antimitotic Agents; Antineoplastic Agents; Autoradiography; Carcinoma; Colonic Neoplasms; Dogs; Glioma; Humans; Intestines; Kidney; Liver; Lymph Nodes; Metabolism; Neoplasms; Pharmacology; Podophyllin; Podophyllotoxin; Podophyllum; Tritium	1964
[A SUPPLEMENT TO CANCER OPERATIONS BY PODOPHYLLIN DERIVATIVES]. Schweizerische medizinische Wochenschrift, 1964, Nov-28, Volume: 94 Topics: Antineoplastic Agents; Dietary Supplements; Humans; Neoplasms; Podophyllin; Podophyllum; Surgical Procedures, Operative	1964
[CHANGES IN LIP MUCOSA AND SKIN OF RATS RECEIVING PODOPHYLLIN]. Archivio italiano di anatomia e istologia patologica, 1963, Volume: 37 Topics: Lip; Lip Neoplasms; Mucous Membrane; Neoplasms; Neoplasms, Experimental; Pathology; Pharmacology; Podophyllin; Podophyllum; Rats; Research; Toxicology	1963
[RESULTS OF OUR EXPERIENCE WITH SP-I AND SP-G IN THE TREATMENT OF MALIGNANT NEOPLASMS]. Giornale di clinica medica, 1963, Volume: 44 Topics: Antineoplastic Agents; Neoplasms; Podophyllin; Podophyllum; Toxicology	1963
[Possibilities and limitations of additional control of malignant tumors by cytostatics, especially by podophyllin derivatives]. Radiologia clinica, 1962, Volume: 31 Topics: Cytostatic Agents; Humans; Neoplasms; Podophyllin; Podophyllum; Radiotherapy	1962
[A case of melanocarcinoma of the temporal region improved by podophyllin]. Revue medicale de la Suisse romande, 1960, Volume: 80 Topics: Face; Facial Neoplasms; Head; Melanoma; Neoplasms; Podophyllin; Podophyllum; Temporal Lobe	1960
Thoughts of a radiologist in a general hospital on cancer of the bladder. The Journal of urology, 1959, Volume: 82, Issue:2 Topics: Hospitals, General; Neoplasms; Podophyllin; Radiology; Radiotherapy; Urinary Bladder Neoplasms	1959
Some biochemical responses of normal and malignant tissues to tumor-necrotizing agents. Acta - Unio Internationalis Contra Cancrum, 1959, Volume: 15(Suppl 1) Topics: Antineoplastic Agents; Humans; Neoplasms; Podophyllin; Podophyllum	1959
Effects of a podophyllotoxin derivative on tissue culture systems in which human cancer invades normal tissue. Cancer research, 1957, Volume: 17, Issue:4 Topics: Antineoplastic Agents; Humans; Neoplasms; Podophyllin; Podophyllotoxin; Research Design; Tissue Culture Techniques	1957
Disposition of biosynthetically labeled C-14 podophyllotoxin in normal and tumor-bearing animals. Archives internationales de pharmacodynamie et de therapie, 1957, Jul-01, Volume: 111, Issue:2 Topics: Neoplasms; Personality; Podophyllin; Podophyllotoxin	1957
[Prolongation of the life of tumor-bearing animals following the combined administration of podophyllin and TEM]. Gan, 1957, Volume: 48, Issue:4 Topics: Animals; Combined Modality Therapy; Life; Neoplasms; Neoplasms, Experimental; Podophyllin; Triethylenemelamine	1957
Enzyme changes induced in normal and malignant tissues with chemical agents. VI. Effect of acetylpodophyllotoxin-omega-pyridinium chloride on malic-oxidase and on isocitric-oxidase systems of sarcoma 37. Journal of the National Cancer Institute, 1956, Volume: 16, Issue:6 Topics: Animals; Neoplasms; Oxidoreductases; Podophyllin; Sarcoma; Sarcoma 37	1956
[Treatment of cancer of the skin with podophyllin]. Ceskoslovenska onkologia, 1956, Volume: 3, Issue:1 Topics: Humans; Neoplasms; Podophyllin; Skin; Skin Neoplasms	1956
Enzyme changes induced in normal and malignant tissues with chemical agents. IV. Effect of alpha-peltatin on glucose utilization by sarcoma 37 and on the adenosinetriphosphatase, hexokinase, aldolase, and pyridine nucleotide levels of sarcoma 37. Journal of the National Cancer Institute, 1955, Volume: 16, Issue:1 Topics: Adenosine Triphosphatases; Animals; Enzymes; Fructose-Bisphosphate Aldolase; Glucose; Hexokinase; Neoplasms; Nucleotides; Podophyllin; Podophyllotoxin; Pyridines; Sarcoma 37; Sarcoma, Experimental	1955
Enzyme changes induced in normal and malignant tissues with chemical agents. V. Effect of acetylpodophyllotoxin-omega-pyridinium chloride on uricase, adenosine deaminase, nucleoside phosphorylase, and glutamic dehydrogenase activities. Journal of the National Cancer Institute, 1955, Volume: 16, Issue:1 Topics: Adenosine Deaminase; Enzymes; Humans; Neoplasms; Oxidation-Reduction; Pentosyltransferases; Podophyllin; Urate Oxidase	1955
[Results in podophyllotoxin therapy of malignant tumors]. Der Krebsarzt, 1955, Volume: 10, Issue:6 Topics: Humans; Neoplasms; Podophyllin; Podophyllotoxin; Podophyllum	1955
Vascular reactions of normal and malignant tissues in Vivo. VI. The role of hypotension in the action of components of podophyllin on transplanted sarcomas. Journal of the National Cancer Institute, 1954, Volume: 14, Issue:4 Topics: Hypotension; Neoplasm Transplantation; Neoplasms; Podophyllin; Sarcoma	1954
Response of patients with advanced neoplasms to the intravenous administration of alpha-peltatin. Journal of the National Cancer Institute, 1954, Volume: 14, Issue:6 Topics: Administration, Intravenous; Neoplasms; Podophyllin; Podophyllotoxin	1954
The cytological effect of chemicals on ascites sarcomas. I. Partial damage in tumor cells by podophyllin, followed by temporary regression and prolongation of life of tumor-bearing rats. Journal of the National Cancer Institute, 1953, Volume: 13, Issue:5 Topics: Animals; Ascites; Life Support Care; Neoplasms; Podophyllin; Rats; Sarcoma; Sarcoma, Experimental	1953
[Clinical experiences in therapy of malignant tumors with podophyllotoxin]. Medizinische Klinik, 1953, Jan-30, Volume: 48, Issue:5 Topics: Humans; Neoplasms; Podophyllin; Podophyllotoxin	1953
[Anti-neoplastic action of podophyllin]. Bollettino chimico farmaceutico, 1952, Volume: 91, Issue:5 Topics: Neoplasms; Podophyllin	1952
[Modern trends in chemotherapy of tumors]. Minerva medica, 1952, Dec-06, Volume: 43, Issue:98 Topics: Colchicine; Ethers; Folic Acid Antagonists; Hormones; Humans; Mechlorethamine; Mitosis; Neoplasms; Nitrogen Mustard Compounds; Pentamidine; Podophyllin; Poisons; Steroids; Stilbenes; Urethane	1952
Podophyllin treatment of skin carcinomas. Acta dermato-venereologica, 1952, Volume: 32, Issue:1 Topics: Humans; Neoplasms; Podophyllin; Skin Neoplasms	1952
[Podophyllin and its active principles in cancer therapy]. Minerva medica, 1952, Mar-15, Volume: 43, Issue:22 Topics: Humans; Neoplasms; Podophyllin	1952
Preliminary report of lysis of mouse sarcoma 37 by a component isolated from resin of podophyllum. Journal of the American Pharmaceutical Association. American Pharmaceutical Association, 1951, Volume: 40, Issue:5 Topics: Animals; Mice; Neoplasms; Podophyllin; Podophyllum; Resins, Plant; Sarcoma; Sarcoma 37	1951
Damage induced in sarcoma 37 with podophyllin, podophyllotoxin alpha-peltatin, beta-peltatin, and quercetin. Journal of the National Cancer Institute, 1950, Volume: 10, Issue:6 Topics: Animals; Humans; Neoplasms; Podophyllin; Podophyllotoxin; Quercetin; Sarcoma 37	1950
Effect of alpha-peltatin, beta-peltatin, podophyllotoxin on lymphomas and other transplanted tumors. Journal of the National Cancer Institute, 1950, Volume: 10, Issue:6 Topics: Humans; Lymphoma; Neoplasm Transplantation; Neoplasms; Podophyllin; Podophyllotoxin	1950
[Action of podophyllin on experimental sarcoma]. Medicina, 1950, Volume: 10, Issue:4 Topics: Animals; Humans; Neoplasms; Podophyllin; Sarcoma; Sarcoma, Experimental	1950
The treatment of papillomatosis with podophyllin. The Journal of urology, 1950, Volume: 64, Issue:6 Topics: Humans; Neoplasms; Papilloma; Podophyllin	1950
On some chemotherapeutic experiments with podophyllotoxin. Acta physiologica et pharmacologica Neerlandica, 1950, Volume: 1, Issue:4 Topics: Humans; Leukemia; Neoplasms; Podophyllin; Podophyllotoxin	1950
Treatment of juvenile papilloma of the larynx with resin of podophyllum; a preliminary report. Archives of otolaryngology, 1950, Volume: 52, Issue:1 Topics: Adolescent; Humans; Larynx; Neoplasms; Papilloma; Podophyllin; Podophyllum; Resins, Plant	1950
[New treatment of epithelioma, podophyllin therapy (peltacure)]. Schweizerische medizinische Wochenschrift, 1950, Jun-24, Volume: 80, Issue:25 Topics: Carcinoma; Humans; Neoplasms; Neoplasms, Glandular and Epithelial; Podophyllin; Skin	1950
Studies on the mechanisms of podophyllin action on tumors and normal skin. The Proceedings of the Institute of Medicine of Chicago, 1949, Jun-15, Volume: 17, Issue:15 Topics: Humans; Neoplasms; Podophyllin; Skin	1949
Effect of podophyllin on transplanted mouse tumors. The Journal of pharmacology and experimental therapeutics, 1948, Volume: 93, Issue:1 Topics: Animals; Mice; Neoplasm Transplantation; Neoplasms; Podophyllin	1948
Effect of podophyllin on tumor cells in tissue culture. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1947, Volume: 66, Issue:3 Topics: Humans; Immunologic Tests; Neoplasms; Podophyllin; Research Design	1947
Failure of resin of podophyllum in the treatment of verruca vulgaris. Archives of dermatology and syphilology, 1947, Volume: 56, Issue:1 Topics: Adenoma; Humans; Neoplasms; Podophyllin; Podophyllum; Warts	1947
Podophyllin treatment of soft papillomas of the female urethra. American journal of obstetrics and gynecology, 1947, Volume: 53, Issue:4 Topics: Female; Humans; Male; Neoplasms; Papilloma; Podophyllin; Skin Neoplasms; Urethra; Vulva	1947
Effect of podophyllin on transplanted mouse tumors. Federation proceedings, 1947, Volume: 6, Issue:1 Topics: Animals; Mice; Neoplasm Transplantation; Neoplasms; Podophyllin	1947